AKBNK:BISTAkbank T.A.S. Analysis
Data as of 2026-03-11 - not real-time
TRY 75.75
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Akbank trades at a **trailing P/E of 6.9**, well below the industry average of 17.3, and the consensus target price of ~99.8 TRY implies a **31% upside** from the current 75.75 TRY level. The bank posted **63% revenue growth**, a solid **operating margin of 47.6%**, and a **ROE of 20.8%**, while maintaining a **dividend yield of 2.86%** with an ultra‑low payout ratio of 11%, indicating sustainable income. Technically, the stock sits above its 200‑day SMA (68.3) but below the 20‑day SMA (84.9), the **RSI of 38.6** hints at near‑oversold conditions, yet the **MACD is bearish** (line –2.10 vs signal –0.29) and volume is trending down, suggesting short‑term pressure.
The upcoming issuance of a **USD‑denominated perpetual bond** will add to the capital base but also increase leverage, while the bank’s **beta is exceptionally low** (≈0.09) and **30‑day volatility is high** (55%). Despite a **max drawdown of 35%** and a sizable debt load, the low payout, strong profitability, and strong analyst consensus (**strong‑buy**) support a **medium‑ to long‑term buy** stance, tempered by macro‑economic and currency headwinds in Turkey.
The upcoming issuance of a **USD‑denominated perpetual bond** will add to the capital base but also increase leverage, while the bank’s **beta is exceptionally low** (≈0.09) and **30‑day volatility is high** (55%). Despite a **max drawdown of 35%** and a sizable debt load, the low payout, strong profitability, and strong analyst consensus (**strong‑buy**) support a **medium‑ to long‑term buy** stance, tempered by macro‑economic and currency headwinds in Turkey.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near support at 69.3 TRY
- RSI approaching oversold territory
- Bearish MACD momentum with decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant upside to target price (~31%)
- Undervalued valuation relative to peers
- Strong earnings growth and sustainable dividend
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Robust ROE and operating margins
- Low payout ratio ensuring dividend sustainability
- Long‑term growth prospects despite macro‑economic risks
Key Metrics & Analysis
Financial Health
Revenue Growth63.20%
Profit Margin30.09%
P/E Ratio6.9
ROE20.79%
ROA1.84%
P/B Ratio1.3
Op. Cash FlowTRY-572498509824
Industry P/E17.3
Technical Analysis
TrendBullish
RSI38.6
SupportTRY 69.30
ResistanceTRY 93.50
MA 20TRY 84.95
MA 50TRY 81.67
MA 200TRY 68.34
MACDBearish
VolumeDecreasing
Fear & Greed Index76.04
Valuation
Target PriceTRY 99.78
Upside/Downside31.72%
GradeUndervalued
TypeBlend
Dividend Yield2.86%
Risk Assessment
Beta0.09
Volatility55.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.